Halozyme Therapeutics (HALO) EV to CFO (2017 - 2026)
Halozyme Therapeutics' EV to CFO came in at 10.62 for Q2 2026, up 4.5% from 10.17 a year earlier but down 2.0% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EV to CFO (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Halozyme Therapeutics reported EV to CFO of 9.20, up 41.6% year-over-year; for FY2025, it was 11.95, up 8.2% from FY2024.
- Going back by year, EV to CFO was 11.04 in FY2024 (-1.3%), 11.19 in FY2023 (-63.3%), 30.52 in FY2022 (+90.2%) and 16.04 in FY2021 (-83.7%).
- The five-year range for quarterly EV to CFO is 10.17 (Q2 2025) to 30.52 (Q4 2022).
- Year-over-year, EV to CFO increased in four of the last eight quarters, with an average decline of 0.1%.
- The fastest year-over-year change in EV to CFO over five years came in Q4 2022 (growth of 90.2%), and the weakest in Q4 2021 (a decline of 83.7%).
- Business Quant data shows HALO's EV to CFO at 10.84 (Q1 2026), 11.95 (Q4 2025) and 12.96 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.62 |
| Mar 31, 2026 | 10.84 |
| Dec 31, 2025 | 11.95 |
| Sep 30, 2025 | 12.96 |
| Jun 30, 2025 | 10.17 |
| Mar 31, 2025 | 14.11 |
| Dec 31, 2024 | 11.04 |
| Sep 30, 2024 | 16.41 |
| Jun 30, 2024 | 14.52 |
| Mar 31, 2024 | 10.93 |
| Dec 31, 2023 | 11.19 |
| Sep 30, 2023 | 12.37 |
| Jun 30, 2023 | 14.41 |
| Mar 31, 2023 | 17.02 |
| Dec 31, 2022 | 30.52 |
| Sep 30, 2022 | 21.15 |
| Jun 30, 2022 | 20.01 |
| Mar 31, 2022 | 16.31 |
| Dec 31, 2021 | 16.04 |
| Sep 30, 2021 | 18.36 |
API Access
Halozyme Therapeutics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();